89Zr-DFO-YS5
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 89Zr-DFO-YS5, covering 2025-11-12 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer [Phase 1]